Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Tumor: Breast Ratio Study
A completed clinical trial investigating tumor-to-breast ratio in breast cancer and LCIS/DCIS with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated pharmacokinetics and the neoadjuvant activity of combining anastrozole with the Src inhibitor sarac…
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: Promotora Navigator - Culturally Appropriate Patient Navigator [NA]
A completed clinical trial evaluating the Promotora Navigator culturally appropriate patient navigator program for breast cancer screening. …
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer [Phase 1]
Phase 1 pharmacokinetics study evaluating palbociclib in postmenopausal Chinese women with ER-positive, HER2-negative advanced breast cancer…
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast Cancer [Phase 2]
Phase 2 trial update for KN035 combined with trastuzumab and docetaxel in HER2-positive breast cancer is ongoing (status unknown).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Tactile Breast Imaging Sensor for Tumor Malignancy Characterization
A completed clinical trial evaluating a tactile breast imaging sensor for characterizing tumor malignancy in breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer
A completed clinical trial investigating whether DNA markers can predict response after systemic therapy in women with metastatic breast can…
-
CLINICAL_TRIALS trial_result · 2019-07-25Clinical Trial Update: Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer [Phase 3]
Phase 3 trial investigating traditional Chinese medicine formula LC09 to treat hand-foot syndrome in patients receiving capecitabine for col…
-
CLINICAL_TRIALS trial_result · 2019-07-25Clinical Trial Update: Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant ) [Phase 2]
A Phase 2 clinical trial evaluating pyrotinib in combination with fulvestrant in HR+/HER2+ metastatic breast cancer is in progress, with sta…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery [Phase 2]
Phase 2 trial evaluating capecitabine with radiation therapy after surgery for nonmetastatic breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Monitoring and Predicting Chemotherapy Response Using DOSI [NA]
Clinical trial update on monitoring and predicting chemotherapy response using DOSI in breast cancer; study completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: A Study to Assess the Feasibility of an E-Health System (ZEMY) Designed to Manage Symptoms in Participants With Breast Cancer Under Anti-Cancer Treatment [Phase 2]
Phase 2 trial update on an e-health system (ZEMY) designed to manage symptoms in participants undergoing anti-cancer treatment for breast ca…
-
CLINICAL_TRIALS trial_result · 2019-07-18Clinical Trial Update: Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients [Phase 1]
Phase 1 trial evaluating safety, biodistribution, radiation dosimetry, and tumor imaging potential of [131I]-SGMIB Anti-HER2 VHH1 in healthy…
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC) [Phase 2]
A Phase 2 trial of nintedanib for HER2-negative metastatic inflammatory breast cancer was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update evaluating selective neoadjuvant treatment by immunohistochemical subtype for HER2-negative breast cancer pati…
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating the degree of biological changes after short-term preoperative endocrine therapy in luminal breast cance…
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating Caelyx (liposomal doxorubicin), cyclophosphamide, and Herceptin in metastatic breast cancer; result…
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial investigating prophylactic octreotide to prevent or reduce diarrhea in patients receiving lapatinib with capecitabine…
-
CLINICAL_TRIALS trial_result · 2019-07-12Clinical Trial Update: A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating abemaciclib plus tamoxifen or abemaciclib alone in women with metastatic breast cancer; results were posted in July…
-
CLINICAL_TRIALS trial_result · 2019-07-12Clinical Trial Update: FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients [Phase 3]
Phase 3 trial comparing FAC vs FAC plus weekly paclitaxel as adjuvant treatment in node-negative high-risk breast cancer; results posted aft…
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors [Phase 2]
Phase 2 trial investigating BMS-754807 with letrozole or alone in hormone receptor-positive breast cancer with resistance to non-steroidal a…
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel Versus Placebo + Trastuzumab + Docetaxel in Previously Untreated Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating pertuzumab plus trastuzumab and docetaxel versus placebo plus trastuzumab and docetaxel in untreated HER2-positive …
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery [Phase 3]
Phase 3 clinical trial update on paravertebral block with ropivacaine before breast cancer surgery.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women [Phase 3]
Phase 3 trial comparing bevacizumab added to endocrine therapy versus endocrine therapy alone as first-line treatment in postmenopausal wome…
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study [Phase 2]
Phase 2 randomized study evaluating capecitabine combined with an aromatase inhibitor versus aromatase inhibitors alone in HR-positive metas…